Clinical Features & Natural History of Acute-on-Chronic Liver Failure in

Status Suspended

Clinical Trial Summary

Chronic liver disease including liver cirrhosis is still associated with high mortality, although advancement of medical management and transplantation. Acute-on-chronic liver failure (ACLF) refers to condition of previously stable chronic liver disease with occurrence of an acute insult resulting in rapid deterioration of liver function and subsequent decompensation. This condition is different from liver cirrhosis (chronic hepatic decompensation) in terms of having more chance of recovery with management before acute deterioration, although it shows high short-term mortality. Thus, earlier recognition and intensive management are important for this condition. However, the definition or diagnostic criteria is unclear and the natural course of this condition is not definitely investigated. The aim of this study is to establish the natural course of ACLF in Korean patients.

Clinical Trial Description

Chronic liver disease including liver cirrhosis is still associated with high mortality, although advancement of medical management and transplantation. Acute-on-chronic liver failure (ACLF) refers to condition of previously stable chronic liver disease with occurrence of an acute insult resulting in rapid deterioration of liver function and subsequent decompensation. Various factors could be a precipitating factor of ACLF. This condition is different from liver cirrhosis (chronic hepatic decompensation) in terms of having more chance of recovery with management before acute deterioration, although it shows high short-term mortality. Thus, earlier recognition and intensive management are important for this condition. However, the definition or diagnostic criteria is unclear and the natural course of this condition is not definitely investigated. The aim of this study is to establish the common etiology, symptom and natural course of ACLF in Korean patients. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02650011
Study type	Observational
Source	Chuncheon Sacred Heart Hospital
Contact
Status	Suspended
Phase
Start date	October 2015
Completion date	December 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03704792` - Validation of the Second Generation of the Controlled Attenuation Parameter (CAP) Using the MRI-PDFF as Reference	N/A
Terminated	`NCT02949375` - Trial to Examine the Effect of Two Doses of GRI-0621 in Patients With Chronic Liver Disease	Phase 2
Active, not recruiting	`NCT01205074` - ¹³C-Methacetin Breath Test (MBT) Methodology Study	Phase 2/Phase 3
Completed	`NCT00756171` - Colesevelam Versus Placebo in Cholestatic Pruritus	Phase 2/Phase 3
Completed	`NCT01195181` - Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.	Phase 4
Completed	`NCT05044663` - Liver and Splenic Stiffness in Predicting Esophageal Varices Needing Treatment in NASH Related Compensated Advanced Chronic Liver Disease.
Recruiting	`NCT04588077` - Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis	Phase 4
Recruiting	`NCT04802954` - Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk Patients	N/A
Recruiting	`NCT04622449` - Etiopathogenesis of Anemia in Chronic Liver Disease
Enrolling by invitation	`NCT05836246` - The Development of Quantitative Ultrasound Imaging Software Platform
Completed	`NCT03087344` - Postprandial Liver and Spleen Stiffness Measurements in the Noninvasive Diagnosis of Cirrhosis	N/A
Completed	`NCT04751045` - Comparison and Outcomes of Endoscopic Ultrasound Liver Biopsies Versus Percutaneous Liver Biopsies	N/A
Not yet recruiting	`NCT04526548` - A Diagnostic Study on Patients With Drug-induced Liver Injury
Withdrawn	`NCT02899325` - FDGal PET/CT to Detect Hepatocellular Carcinoma
Terminated	`NCT02530567` - Non-invasive Evaluation of Portal Pressure by MRI	N/A
Completed	`NCT01851252` - MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy	Phase 1
Terminated	`NCT01756690` - Predicting Lung Injury From Transfusion in Patients With Liver Disease	N/A
Completed	`NCT01600105` - Detection of Liver Fibrosis With Magnetic Resonance Imaging (MRI)	Phase 4
Completed	`NCT01008293` - Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of Life	Phase 2/Phase 3
Completed	`NCT01634698` - Relative-dose-response Test (RDR) Adaptation for Chronic Liver Disease	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Features and Natural History of Acute-on-Chronic Liver Failure in Korean Patients With Chronic Liver Disease

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms